Kewei Zhao

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Glutathione S-transferase inhibitor NBDHEX induces ROS-dependent immunogenic cell death and enhances PD-1 blockade in DLBCL.

Glutathione S-transferase inhibitor NBDHEX induces ROS-dependent immunogenic cell death and enhances PD-1 blockade in DLBCL.

Journal: Cell communication and signaling : CCS

Published: August 07, 2025

Clinical application of 90-gene expression test in a patient with occult breast cancer: a case report and literature review.

Clinical application of 90-gene expression test in a patient with occult breast cancer: a case report and literature review.

Journal: Breast cancer (Tokyo, Japan)

Published: April 04, 2025

Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review.

Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review.

Journal: Frontiers in oncology

Published: March 30, 2025

Identification of oxidative stress-related hub genes for predicting prognosis in diffuse large B-cell lymphoma.

Identification of oxidative stress-related hub genes for predicting prognosis in diffuse large B-cell lymphoma.

Journal: Gene

Published: July 13, 2024

Single-cell transcriptome sequencing provides insight into multiple chemotherapy resistance in a patient with refractory DLBCL: a case report.

Single-cell transcriptome sequencing provides insight into multiple chemotherapy resistance in a patient with refractory DLBCL: a case report.

Journal: Frontiers in immunology

Published: September 27, 2023

Tissue-Matched IgH Gene Rearrangement of Circulating Tumor DNA Shows Significant Value in Predicting the Progression of Diffuse Large B Cell Lymphoma.

Tissue-Matched IgH Gene Rearrangement of Circulating Tumor DNA Shows Significant Value in Predicting the Progression of Diffuse Large B Cell Lymphoma.

Journal: The oncologist

Published: July 25, 2023

The association between the neuroendocrine system and the tumor immune microenvironment: Emerging directions for cancer immunotherapy.

The association between the neuroendocrine system and the tumor immune microenvironment: Emerging directions for cancer immunotherapy.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: June 08, 2023

A new prognostic nomogram in patients with mucosa-associated lymphoid tissue lymphoma: a multicenter retrospective study.

A new prognostic nomogram in patients with mucosa-associated lymphoid tissue lymphoma: a multicenter retrospective study.

Journal: Frontiers in oncology

Published: December 14, 2022

Tumor to liver maximum standardized uptake value ratio of FDG-PET/CT parameters predicts tumor treatment response and survival of stage III non-small cell lung cancer.

Tumor to liver maximum standardized uptake value ratio of FDG-PET/CT parameters predicts tumor treatment response and survival of stage III non-small cell lung cancer.

Journal: BMC medical imaging

Published: September 28, 2022

Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis.

Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis.

Journal: The oncologist

Published: September 19, 2022

Secondary mutant ALK-I1171s in pituitary metastases from a patient with ALK fusion-positive advanced lung adenocarcinoma: A case report and literature review.

Secondary mutant ALK-I1171s in pituitary metastases from a patient with ALK fusion-positive advanced lung adenocarcinoma: A case report and literature review.

Journal: Frontiers in oncology

Published: August 10, 2022

Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation.

Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation.

Journal: Frontiers in oncology

Published: July 21, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026